TerrAscend Corp. (TSND.TO)

CAD 0.37

(-6.41%)

Revenue Summary of TerrAscend Corp.

TerrAscend Corp.'s latest annual revenue in 2023 was 317.32 Million USD , up 32.75% from previous year.
TerrAscend Corp.'s latest quarterly revenue in 2024 Q2 was 77.52 Million USD , down -28.71% from previous quarter.
TerrAscend Corp. reported a annual revenue of 322.63 Million USD in annual revenue 2022, up 32.51% from previous year.
TerrAscend Corp. reported a annual revenue of 243.48 Million USD in annual revenue 2021, up 22.78% from previous year.
TerrAscend Corp. reported a quarterly revenue of 108.74 Million USD for 2024 Q1, down -7.77% from previous quarter.
TerrAscend Corp. reported a quarterly revenue of 117.9 Million USD for 2023 Q4, down -1.5% from previous quarter.

Annual Revenue Chart of TerrAscend Corp. (2023 - 2016)

Historical Annual Revenue of TerrAscend Corp. (2023 - 2016)

Year	Revenue	Revenue Growth
2023	317.32 Million USD	32.75%
2022	322.63 Million USD	32.51%
2021	243.48 Million USD	22.78%
2020	198.31 Million CAD	133.68%
2019	84.86 Million CAD	1143.31%
2018	6.82 Million CAD	0.0%
2017	- CAD	0.0%
2016	- CAD	0.0%

Year	Revenue	Revenue Growth
2024 Q2	77.52 Million USD	-28.71%
2024 Q1	108.74 Million USD	-7.77%
2023 Q4	117.9 Million USD	-1.5%
2023 Q1	93.86 Million USD	4.22%
2023 Q2	96.86 Million USD	3.2%
2023 Q3	119.69 Million USD	23.57%
2023 FY	428.29 Million USD	32.75%
2022 Q3	87.54 Million CAD	5.8%
2022 Q1	62.89 Million CAD	1.41%
2022 FY	322.63 Million USD	32.51%
2022 Q4	90.06 Million CAD	2.88%
2022 Q2	82.74 Million CAD	31.56%
2021 Q4	62.02 Million CAD	0.17%
2021 FY	243.48 Million USD	22.78%
2021 Q3	61.91 Million CAD	0.0%
2020 FY	198.31 Million CAD	133.68%
2019 FY	84.86 Million CAD	1143.31%
2018 FY	6.82 Million CAD	0.0%
2017 FY	- CAD	0.0%
2016 FY	- CAD	0.0%

Peer Revenue Comparison of TerrAscend Corp.

Name	Revenue	Revenue Difference
Aurora Cannabis Inc.	270.28 Million CAD	-17.407%
Avicanna Inc.	16.79 Million CAD	-1789.815%
Avant Brands Inc.	26.34 Million CAD	-1104.555%
Cardiol Therapeutics Inc.	- CAD	-Infinity%
Crescita Therapeutics Inc.	17.52 Million CAD	-1711.026%
Knight Therapeutics Inc.	328.19 Million CAD	3.312%
MediPharm Labs Corp.	33.06 Million CAD	-859.797%
OrganiGram Holdings Inc.	149.2 Million CAD	-112.679%
Canopy Growth Corporation	297.14 Million CAD	-6.792%
Willow Biosciences Inc.	1.17 Million CAD	-26975.768%
Auxly Cannabis Group Inc.	101.07 Million CAD	-213.944%